Knollwood Investment Advisory LLC trimmed its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 38.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,881 shares of the semiconductor company’s stock after selling 5,450 shares during the period. Knollwood Investment Advisory LLC’s holdings in Synopsys were worth $4,382,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of SNPS. Vanguard Group Inc. lifted its position in shares of Synopsys by 20.7% during the third quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock worth $8,970,415,000 after acquiring an additional 3,120,401 shares in the last quarter. State Street Corp raised its stake in shares of Synopsys by 1.2% during the 2nd quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock valued at $3,725,362,000 after purchasing an additional 85,662 shares during the period. Victory Capital Management Inc. lifted its holdings in Synopsys by 238.8% during the 3rd quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock worth $1,393,506,000 after purchasing an additional 1,990,608 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in Synopsys by 29.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after purchasing an additional 585,494 shares during the period. Finally, Capital Research Global Investors grew its holdings in Synopsys by 226.6% during the 3rd quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock valued at $1,245,533,000 after buying an additional 1,751,432 shares in the last quarter. Institutional investors own 85.47% of the company’s stock.
Insider Buying and Selling
In other news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Janet Lee sold 250 shares of Synopsys stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider directly owned 11,959 shares of the company’s stock, valued at $6,338,270. This represents a 2.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 4,157 shares of company stock valued at $1,945,036. Corporate insiders own 0.56% of the company’s stock.
Synopsys Stock Performance
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping the consensus estimate of $3.56 by $0.21. The company had revenue of $2.41 billion during the quarter, compared to analyst estimates of $2.39 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.Synopsys’s revenue was up 65.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, equities analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on SNPS. KeyCorp upped their price target on Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. HSBC lowered shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective for the company. in a research report on Friday, February 20th. Morgan Stanley reaffirmed an “equal weight” rating and set a $480.00 target price (down from $550.00) on shares of Synopsys in a report on Wednesday, February 25th. Piper Sandler lowered their target price on shares of Synopsys from $520.00 to $430.00 and set a “neutral” rating on the stock in a research note on Thursday, February 26th. Finally, Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Eight research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $531.00.
Read Our Latest Report on SNPS
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
